Biotage

Board/Management Information • May 10, 2021

Press release Biotage AB

Contactperson: SE-751 03 Uppsala Tomas Blomquist, CEO & President Tel:018 56 59 00 Tel: 0705 23 01 63, tomas.blomquist@biotage.com www.biotage.com

Box 8

Uppsala May 10, 2021

Annette Colin has today informed Biotage that she is leaving the position as CFO. Annette Colin has a six months' notice period. The company will now initiate the recruitment of a successor.

This information was submitted for publication, through the agency of the contact persons set out above, at 14.00 CET on May 10, 2021.

About Biotage

Biotage is a Global Impact Tech Company committed to solving society's problems. We offer workflow solutions and products to customers in drug discovery and development, analytical testing and water and environmental testing.

Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.

Our customers span a broad range of market segments including pharmaceutical, biotech, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.

Biotage is headquartered in Uppsala in Sweden and employs approx. 485 people worldwide. The Group had sales of 1,092 MSEK in 2020 and our products are sold in more than 70 countries. Biotage's share (BIOT) is listed in the Mid Cap segment on the NASDAQ Stockholm. Website: www.biotage.com